Pioglitazone as a therapeutic agent in autistic spectrum disorder.
Emanuele
Enzo
E
Lossano
Cecilia
C
Politi
Pierluigi
P
Barale
Francesco
F
D002986:Clinical Trials as Topic; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007249:Inflammation; D008954:Models, Biological; D008962:Models, Theoretical; D010766:Phosphorylation; D000077205:Pioglitazone; D017434:Protein Structure, Tertiary; D019859:Proto-Oncogene Proteins c-met / Q000378:metabolism; D015398:Signal Transduction; D045162:Thiazolidinediones / Q000627:therapeutic use*; D016896:Treatment Outcome
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D019859:Proto-Oncogene Proteins c-met; D000077205:Pioglitazone